The study of pathogenicity and virulence of fungal strains, in vivo in the preclinical phase, is carried out through the use of animal models belonging to various classes of mammals (rodents, leproids, etc.). Although animals are functionally more similar to humans, these studies have some limitations in terms of ethics (animal suffering), user-friendliness, cost-effectiveness, timing (physiological response time) and logistics (need for adequately equipped laboratories). A good in vivo model must possess some optimal characteristics to be used, such as rapid growth, small size and short life cycle. For this reason, insects, such as Galleria mellonella (Lepidoptera), Drosophila melanogaster (Diptera) and Bombyx mori (Lepidoptera), have been widely used as alternative non-mammalian models. Due to their simplicity of use and low cost, the larvae of G. mellonella represent an optimal model above all to evaluate the virulence of fungal pathogens and the use of antifungal treatments (either single or in combination with biologically active compounds). A further advantage is also represented by their simple neuronal system limiting the suffering of the animal itself, their ability to survive at near-body ambient temperatures as well as the expression of proteins able to recognise combined pathogens following the three R principles (replacement, refinement and reduction). This review aims to assess the validity as well as the advantages and disadvantages of replacing mammalian classes with G. mellonella as an in vivo study model for preclinical experimentation.
The success of antimicrobial compounds today is diminished by the ability of microbes to develop resistance. The use of natural compounds as alternatives to antibiotics and/or antifungals is increasing. The potential use of essential oils, particularly their phenolic compounds, thymol or carvacrol, is receiving great interest. The study aims to evaluate the antimicrobial activity of the two monoterpenes against Gram‐positive and ‐negative bacteria and various Candida spp., in planktonic form, through MIC and MBC/MFC evaluation, and sessile growth form, through crystal violet and XTT assays. In addition, Checkerboard test evaluated synergistic effects between the phenolic compounds, and phenolic compounds and antibiotics/antimycotics substances, and cytotoxicity versus three different human cell lines was evaluated through MTT assay. Results obtained showed antimicrobial activity of the phenolic compounds against bacteria and Candida spp., in both planktonic and sessile cultures. The MIC/MBC range of carvacrol and thymol was 125–250 µg/mL against all strains tested, while for Candida spp., the MIC/MFCs ranged from 250 to 2000 µg/mL. Several combinations of monoterpenes/antimicrobial compounds showed synergistic or additive effects at concentrations lower than MIC values in both planktonic and sessile forms. Carvacrol was toxic to all the tested cell lines (concentrations > 31 µg/mL); whereas thymol was toxic to only two of the tested cell lines (human urinary cell line excluded). In conclusion, although a high level of cytotoxicity against different cell lines has been demonstrated, the additive and synergistic effects shown could allow their therapeutic use at nontoxic concentrations, encouraging further studies on these substances.
Emerging life-threatening multidrug-resistant (MDR) species such as the C. haemulonii species complex, Clavispora lusitaniae (sin. C. lusitaniae), and other Candida species are considered as an increasing risk for human health in the near future. (1) Background: Many studies have emphasized that the increase in drug resistance can be associated with several virulence factors in Candida and its knowledge is also essential in developing new antifungal strategies. (2) Methods: Hydrophobicity, adherence, biofilm formation, lipase activity, resistance to osmotic stress, and virulence ‘in vivo’ on G. mellonella larvae were studied in isolates of C. haemulonii, C. albicans, and C. lusitaniae with low susceptibility and resistance to fluconazole and amphotericin B. (3) Results: Intra- and interspecies variability were observed. C. haemulonii showed high hydrophobicity and the ability to adhere to and form biofilm. C. lusitaniae was less hydrophobic, was biofilm-formation-strain-dependent, and did not show lipase activity. Larvae inoculated with C. albicans isolates displayed significantly higher mortality rates than those infected with C. haemulonii and C. lusitaniae. (4) Conclusions: The ability to adhere to and form biofilms associated with their hydrophobic capacity, to adapt to stress, and to infect within an in vivo model, observed in these non-wild-type Candida and Clavispora isolates, shows their marked virulence features. Since factors that define virulence are related to the development of the resistance of these fungi to the few antifungals available for clinical use, differences in the physiology of these cells must be considered to develop new antifungal therapies.
Background/Objectives: There is an increasing incidence of fungal infections in conjunction with the rise in resistance to medical treatment. Antimicrobial resistance is frequently associated with virulence factors such as adherence and the capacity of biofilm formation, which facilitates the evasion of the host immune response and resistance to drug action. Novel therapeutic strategies have been developed to overcome antimicrobial resistance, including the use of different type of nanomaterials: metallic (Au, Ag, Fe3O4 and ZnO), organic (e.g., chitosan, liposomes and lactic acid) or carbon-based (e.g., quantum dots, nanotubes and graphene) materials. The objective of this study was to evaluate the action of nanoparticles of different synthesis and with different coatings on fungi of medical interest. Methods: Literature research was conducted using PubMed and Google Scholar databases, and the following terms were employed in articles published up to June 2025: ‘nanoparticles’ in combination with ‘fungal biofilm’, ‘Candida biofilm’, ‘Aspergillus biofilm’, ‘Cryptococcus biofilm’, ‘Fusarium biofilm’ and ‘dermatophytes biofilm’. Results: The utilization of nanoparticles was found to exert a substantial impact on the reduction in fungal biofilm, despite the presence of substantial variability in minimum inhibitory concentration (MIC) values attributable to variations in nanoparticle type and the presence of capping agents. It was observed that the MIC values were lower for metallic nanoparticles, particularly silver, and for those synthesized with polylactic acid compared to the others. Conclusions: Despite the limited availability of data concerning the stability and biocompatibility of nanoparticles employed in the treatment of fungal biofilms, it can be posited that these results constitute a significant initial step.
15 March 2024 in Carbohydrate Polymer Technologies and Applications
Burn wounds are debilitating injuries that contribute significantly to global morbidity and mortality. The disruption of skin integrity elevates the risk of infection, which can impede healing and potentially lead to sepsis. Furthermore, antibiotic resistance, primarily driven by biofilm formation, poses a major challenge to effective treatment. This study is aimed at evaluating the potential of positively charged carbon dots (CDs) in inhibiting biofilm formation, with possible applications in wound care. Specifically, carbon nanodots (CDs‐NH 2 ) were tested in vitro against both planktonic cells and biofilms formed by a range of pathogens, including the Gram‐positive bacterium Staphylococcus aureus , the Gram‐negative bacterium Escherichia coli , the yeast Candida albicans , and the mold Aspergillus brasiliensis . Additionally, the activity of CDs‐NH 2 was assessed against polymicrobial biofilms composed of S. aureus and C. albicans . The in vivo efficacy of CDs‐NH 2 was evaluated using the Galleria mellonella burn wound infection model for both monomicrobial and polymicrobial infections. The ability of CDs‐NH 2 to penetrate fungal cells was demonstrated by fluorescence microscopy analysis. Biomass quantification showed that CDs‐NH 2 reduced biofilm formation by over 50% for C. albicans , E. coli , and A. brasiliensis , as well as for C. albicans – S. aureus cocultures, at concentrations below 62.5 μ g/mL. The in vivo studies further confirmed the antimicrobial activity of CDs‐NH 2 against all tested strains in burn wound infections. Strategies that target biofilm‐forming microorganisms at wound sites may enhance infection control and promote wound healing.